Cardiology Research and Practice [137] F. H. Nystrom and M. Quon, “Insulin signalling: metabolic pathways and mechanisms for speciﬁcity,” Cellular Signalling, vol. 11, no. 8, pp. 563–574, 1999. [138] V. Adams, A. Linke, N. Kra¨nkel et al., “Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease,” Circulation, vol. 111, no. 5, pp. 555–562, 2005. [139] L. K. Kelly, S. Wedgwood, R. H. Steinhorn, and S. M. Black, “Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclise,” American Journal of Physiology, vol. 286, no. 5, pp. L984–L991, 2004. [140] R. Muniyappa, M. Iantorno, and M. J. Quon, “An integrated view of insulin resistance and endothelial dysfunction,” Endocrinology and Metabolism Clinics of North America, vol. 37, no. 3, pp. 685–711, 2008. [141] A. Lteif, P. Vaishnava, A. D. Baron, and K. J. Mather, “Endothelin limits insulin action in obese/insulin-resistant humans,” Diabetes, vol. 56, no. 3, pp. 728–734, 2007. [142] G. Ahlborg, A. Shemyakin, F. Bo¨hm, A. Gonon, and J. Per- now, “Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease,” Diabetes Care, vol. 30, no. 3, pp. 591–596, 2007. [143] M. A. Vincent, M. Montagnani, and M. J. Quon, “Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium,” Current Diabetes Reports, vol. 3, no. 4, pp. 279–288, 2003. [144] M. Montagnani, H. Chen, V. A. Barr, and M. J. Quon, “Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser,” Journal of Biological Chemistry, vol. 276, no. 32, pp. 30392–30398, 2001. [145] F. Schinzari, M. Tesauro, V. Rovella et al., “Generalized impairment of vasodilator reactivity during hyperinsuline- mia in patients with obesity-related metabolic syndrome,” American Journal of Physiology, vol. 299, no. 6, pp. E947– E952, 2010. [146] V. J. Stevens, E. Obarzanek, N. R. Cook et al., “Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II,” Annals of Internal Medicine, vol. 134, no. 1, pp. 1–11, 2001. 11